{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:34:54Z","timestamp":1787016894858,"version":"build-2736575974"},"reference-count":46,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007427","name":"Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["4-43006578"],"award-info":[{"award-number":["4-43006578"]}],"id":[{"id":"10.13039\/501100007427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"crossref","award":["IR.NIMAD.REC.1394.013"],"award-info":[{"award-number":["IR.NIMAD.REC.1394.013"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2023,9,9]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We evaluate which screening and diagnostic approach resulted in the greatest reduction in adverse pregnancy outcomes due to increased treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>This study presents a secondary analysis of a randomized community non-inferiority trial conducted among pregnant women participating in the GULF Study in Iran. A total of 35\u2009430 pregnant women were randomly assigned to one of the five prespecified gestational diabetes mellitus (GDM) screening protocols. The screening methods included fasting plasma glucose (FPG) in the first trimester and either a one-step or a two-step screening method in the second trimester of pregnancy. According to the results, participants were classified into 6 groups (1) First-trimester FPG: 100\u2013126\u2009mg\/dL, GDM diagnosed at first trimester; (2) First trimester FPG: 92\u201399.9\u2009mg\/dL, GDM diagnosed at first trimester; (3) First trimester FPG: 92\u201399.9\u2009mg\/dL, GDM diagnosed at second trimester; (4) First trimester FPG: 92\u201399.9\u2009mg\/dL, healthy at second trimester; (5) First trimester FPG&lt;92\u2009mg\/dL, GDM diagnosed at second trimester; (6) First trimester FPG&lt;92\u2009mg\/dL, healthy at second trimester. For our analysis, we initially used group 6, as the reference and repeated the analysis using group 2, as the reference group. The main outcome of the study was major adverse maternal and neonatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Macrosomia and primary caesarean section occurred in 9.8% and 21.0% in group 1, 7.8% and 19.8% in group 2, 5.4% and 18.6% in group 3, 6.6% and 21.5% in group 4, 8.3% and 24.0% in group 5, and 5.4% and 20.0% in group 6, respectively. Compared with group 6 as the reference, there was a significant increase in the adjusted risk of neonatal intensive care unit (NICU) admission in groups 1, 3, and 5 and an increased risk of macrosomia in groups 1, 2, and 5. Compared with group 2 as the reference, there was a significant decrease in the adjusted risk of macrosomia in group 3, a decreased risk of NICU admission in group 6, and an increased risk of hyperglycemia in group 3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We conclude that screening approaches for GDM reduced the risk of adverse pregnancy outcomes to the same or near the same risk level of healthy pregnant women, except for the risk of NICU admission that increased significantly in groups diagnosed with GDM compared with healthy pregnant women. Individuals with slight increase in FPG (92\u2013100\u2009mg\/dL) at first trimester, who were diagnosed as GDM, had an even increased risk of macrosomia in comparison to those group of women with FPG 92\u2013100\u2009mg\/dL in the first trimester, who were not diagnosed with GDM, and developed GDM in second trimester<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>IRCT138707081281N1 (registered: February 15, 2017).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2023-003510","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T23:20:11Z","timestamp":1702423211000},"page":"e003510","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Various screening and diagnosis approaches for gestational diabetes mellitus and adverse pregnancy outcomes: a secondary analysis of a randomized non-inferiority field trial"],"prefix":"10.1136","volume":"11","author":[{"given":"Fahimeh","family":"Ramezani Tehrani","sequence":"first","affiliation":[{"name":"Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sheidaei","sequence":"additional","affiliation":[{"name":"School of Public Health, Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rahmati","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Noroozzadeh","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Hosseinpanah","sequence":"additional","affiliation":[{"name":"Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrandokht","family":"Abedini","sequence":"additional","affiliation":[{"name":"Infertility and Cell Therapy Office, Transplant & DiseaseTreatment Center, Ministry of Health and Medical Education, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[{"name":"Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Valizadeh","sequence":"additional","affiliation":[{"name":"Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Torkestani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Shahed University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Khalili","sequence":"additional","affiliation":[{"name":"Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faegheh","family":"Firouzi","sequence":"additional","affiliation":[{"name":"Tehran Medical Branch, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Solaymani-Dodaran","sequence":"additional","affiliation":[{"name":"Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Ostovar","sequence":"additional","affiliation":[{"name":"Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[{"name":"Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-640X","authenticated-orcid":false,"given":"Samira","family":"Behboudi-Gandevani","sequence":"additional","affiliation":[{"name":"Faculty of Nursing and Health Sciences, Nord University, Bod\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"2025073112380977000_11.6.e003510.1","first-page":"LE01","article-title":"Screening in public health and clinical care: similarities and differences in definitions, types, and aims - a systematic review","volume":"11","author":"Speechley","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"2025073112380977000_11.6.e003510.2","doi-asserted-by":"crossref","unstructured":"Behboudi-Gandevani S , Amiri M , Bidhendi Yarandi R , et al . The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis. Diabetol Metab Syndr 2019;11. doi:10.1186\/s13098-019-0406-1","DOI":"10.1186\/s13098-019-0406-1"},{"key":"2025073112380977000_11.6.e003510.3","doi-asserted-by":"crossref","unstructured":"Paulo MS , Abdo NM , Bettencourt-Silva R , et al . Gestational diabetes mellitus in Europe: a systematic review and meta-analysis of prevalence studies. Front Endocrinol (Lausanne) 2021;12. doi:10.3389\/fendo.2021.691033","DOI":"10.3389\/fendo.2021.691033"},{"key":"2025073112380977000_11.6.e003510.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067946","article-title":"Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis","volume":"377","author":"Ye","year":"2022","journal-title":"BMJ"},{"key":"2025073112380977000_11.6.e003510.5","doi-asserted-by":"crossref","unstructured":"Bidhendi Yarandi R , Vaismoradi M , Panahi MH , et al . Mild gestational diabetes and adverse pregnancy outcome: a systemic review and meta-analysis. Front Med (Lausanne) 2021;8. doi:10.3389\/fmed.2021.699412","DOI":"10.3389\/fmed.2021.699412"},{"key":"2025073112380977000_11.6.e003510.6","doi-asserted-by":"crossref","unstructured":"Behboudi-Gandevani S , Bidhendi-Yarandi R , Panahi MH , et al . The effect of mild gestational diabetes mellitus treatment on adverse pregnancy outcomes: a systemic review and meta-analysis. Front Endocrinol (Lausanne) 2021;12. doi:10.3389\/fendo.2021.640004","DOI":"10.3389\/fendo.2021.640004"},{"key":"2025073112380977000_11.6.e003510.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000314","article-title":"Gestational diabetes mellitus treatment reduces obesity-induced adverse pregnancy and neonatal outcomes: the St. Carlos gestational study","volume":"4","author":"Assaf-Balut","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2025073112380977000_11.6.e003510.8","doi-asserted-by":"crossref","unstructured":"Vounzoulaki E , Khunti K , Abner SC , et al . Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020;369. doi:10.1136\/bmj.m1361","DOI":"10.1136\/bmj.m1361"},{"key":"2025073112380977000_11.6.e003510.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.11922"},{"key":"2025073112380977000_11.6.e003510.10","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1848"},{"key":"2025073112380977000_11.6.e003510.11","unstructured":"World Health Organization . Diagnostic Criteria And Classification Of Hyperglycaemia First Detected In Pregnancy. Geneva: World Health Organization, 2013."},{"key":"2025073112380977000_11.6.e003510.12","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S002"},{"key":"2025073112380977000_11.6.e003510.13","unstructured":"National Institute for Health and Care Excellence. NICE guideline . Diabetes in pregnancy: management from preconception to the postnatal period (NG3). London: NICE, Available: http:\/\/www.nice.org.uk\/guida [accessed Jul 2017]."},{"key":"2025073112380977000_11.6.e003510.14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12884-018-1809-y","article-title":"The treatment of booking gestational diabetes mellitus (TOBOGM) pilot randomised controlled trial","volume":"18","author":"Simmons","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025073112380977000_11.6.e003510.15","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1157"},{"key":"2025073112380977000_11.6.e003510.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2012.03.006"},{"key":"2025073112380977000_11.6.e003510.17","doi-asserted-by":"crossref","first-page":"e836","DOI":"10.1210\/clinem\/dgaa831","article-title":"Women with mild fasting hyperglycemia in early pregnancy have more neonatal intensive care admissions","volume":"106","author":"Benhalima","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2025073112380977000_11.6.e003510.18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/jcm10040666","article-title":"The impact of diagnostic criteria for gestational diabetes mellitus on adverse maternal outcomes: a systematic review and meta-analysis","volume":"10","author":"Ramezani Tehrani","year":"2021","journal-title":"J Clin Med"},{"key":"2025073112380977000_11.6.e003510.19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4093\/dmj.2021.0178","article-title":"Effect of different types of diagnostic criteria for gestational diabetes mellitus on adverse neonatal outcomes: a systematic review, meta-analysis, and meta-regression","volume":"46","author":"Tehrani","year":"2022","journal-title":"Diabetes Metab J"},{"key":"2025073112380977000_11.6.e003510.20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/14767058.2013.799656","article-title":"To evaluate the prevalence and clinical outcomes using a one-step method versus a two-step method to screen gestational diabetes mellitus","volume":"27","author":"Sevket","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025073112380977000_11.6.e003510.21","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1080\/14767058.2017.1408068","article-title":"One step versus two step approach for gestational diabetes screening: systematic review and meta-analysis of the randomized trials","volume":"32","author":"Saccone","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025073112380977000_11.6.e003510.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026028"},{"key":"2025073112380977000_11.6.e003510.23","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-019-0493-z","article-title":"Cost effectiveness of different screening strategies for gestational diabetes mellitus screening: study protocol of a randomized community non-inferiority trial","volume":"11","author":"Ramezani Tehrani","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"2025073112380977000_11.6.e003510.24","doi-asserted-by":"crossref","first-page":"e2906","DOI":"10.1210\/clinem\/dgac181","article-title":"A cluster randomized noninferiority field trial of gestational diabetes mellitus screening","volume":"107","author":"Ramezani Tehrani","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025073112380977000_11.6.e003510.25","unstructured":"The American Colledge of Obstetricians and Gynecologist . Guideline For Perinatal Care. Available: https:\/\/www.buckeyehealthplan.com\/content\/dam\/centene\/Buckeye\/medicaid\/pdfs\/ACOG-Guidelines-for-Perinatal-Care.pdf"},{"key":"2025073112380977000_11.6.e003510.26","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000433006.09219.f1"},{"key":"2025073112380977000_11.6.e003510.27","first-page":"S4","article-title":"Standards of medical care in Diabetes-2016: summary of revisions","volume":"39 Suppl 1","year":"2016","journal-title":"Diabetes Care"},{"key":"2025073112380977000_11.6.e003510.28","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001767"},{"key":"2025073112380977000_11.6.e003510.29","doi-asserted-by":"crossref","unstructured":"Mustafa R , Ahmed S , Gupta A , et al . A comprehensive review of hypertension in pregnancy. J Pregnancy 2012;2012. doi:10.1155\/2012\/105918","DOI":"10.1155\/2012\/105918"},{"key":"2025073112380977000_11.6.e003510.30","doi-asserted-by":"publisher","DOI":"10.3109\/08958378.2014.955932"},{"key":"2025073112380977000_11.6.e003510.31","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150999"},{"key":"2025073112380977000_11.6.e003510.32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/ajo.13116","article-title":"The new gestational diabetes: treatment, evidence and consent","volume":"60","author":"Hegerty","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2025073112380977000_11.6.e003510.33","article-title":"Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews","volume":"8","author":"Martis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025073112380977000_11.6.e003510.34","article-title":"Insulin for the treatment of women with gestational diabetes","volume":"11","author":"Brown","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025073112380977000_11.6.e003510.35","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2214956","article-title":"Treatment of gestational diabetes mellitus diagnosed early in pregnancy","volume":"388","author":"Simmons","year":"2023","journal-title":"N Engl J Med"},{"key":"2025073112380977000_11.6.e003510.36","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa2204091","article-title":"Lower versus higher Glycemic criteria for diagnosis of gestational diabetes","volume":"387","author":"Crowther","year":"2022","journal-title":"N Engl J Med"},{"key":"2025073112380977000_11.6.e003510.37","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002501"},{"key":"2025073112380977000_11.6.e003510.38","article-title":"Iranian endocrine society guidelines for screening, diagnosis, and management of gestational diabetes mellitus","volume":"19","author":"Valizadeh","year":"2021","journal-title":"Int J Endocrinol Metab"},{"key":"2025073112380977000_11.6.e003510.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.01.055"},{"key":"2025073112380977000_11.6.e003510.40","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0014"},{"key":"2025073112380977000_11.6.e003510.41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11892-003-0024-y","article-title":"Free fatty acids, insulin resistance, and pregnancy","volume":"3","author":"Sivan","year":"2003","journal-title":"Curr Diab Rep"},{"key":"2025073112380977000_11.6.e003510.42","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2411"},{"key":"2025073112380977000_11.6.e003510.43","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0102"},{"key":"2025073112380977000_11.6.e003510.44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajog.2018.10.027","article-title":"Gestational diabetes mellitus is associated with adverse outcomes in twin pregnancies","volume":"220","author":"Hiersch","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2025073112380977000_11.6.e003510.45","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030777","article-title":"Risk of obstetric and neonatal morbidity in gestational diabetes in a single institution: a retrospective, observational study","volume":"101","author":"Chung","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2025073112380977000_11.6.e003510.46","doi-asserted-by":"publisher","DOI":"10.1046\/j.0004-8666.2003.00116.x"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2023-003510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:38:25Z","timestamp":1753990705000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2023-003510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,12,12]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bmjdrc-2023-003510"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2023-003510","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}